中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2009年
6期
1010-1011
,共2页
李明霞%尤永森%李明%袁美如
李明霞%尤永森%李明%袁美如
리명하%우영삼%리명%원미여
血浆置换%慢性重型肝炎
血漿置換%慢性重型肝炎
혈장치환%만성중형간염
Plasma exchange%Chronic severe hepatitis
目的 探讨血浆置换(PE)治疗慢性重型肝炎的疗效.方法 将70例慢性重型肝炎住院患者随机分为PE组和对照组,PE组在内科综合治疗基础上联合PE,对照组仅给予内科综合治疗,疗程为1个月.结果 PE组在TBil、ALT、CHO、CHE、PTA、BUN及Cr方面改善明显优于对照组(P<0.05);PE组总有效率为62.86%,对照组为31.43%,PE组明显高于对照组(P<0.05);住院期间内PE组死亡率为11.42%,而对照组高达31.42%,两者比较差异有统计学意义(P<0.05).结论 PE联合内科综合治疗可以明显提高慢性重型肝炎的治疗效果,是一种安全可靠的治疗方法.
目的 探討血漿置換(PE)治療慢性重型肝炎的療效.方法 將70例慢性重型肝炎住院患者隨機分為PE組和對照組,PE組在內科綜閤治療基礎上聯閤PE,對照組僅給予內科綜閤治療,療程為1箇月.結果 PE組在TBil、ALT、CHO、CHE、PTA、BUN及Cr方麵改善明顯優于對照組(P<0.05);PE組總有效率為62.86%,對照組為31.43%,PE組明顯高于對照組(P<0.05);住院期間內PE組死亡率為11.42%,而對照組高達31.42%,兩者比較差異有統計學意義(P<0.05).結論 PE聯閤內科綜閤治療可以明顯提高慢性重型肝炎的治療效果,是一種安全可靠的治療方法.
목적 탐토혈장치환(PE)치료만성중형간염적료효.방법 장70례만성중형간염주원환자수궤분위PE조화대조조,PE조재내과종합치료기출상연합PE,대조조부급여내과종합치료,료정위1개월.결과 PE조재TBil、ALT、CHO、CHE、PTA、BUN급Cr방면개선명현우우대조조(P<0.05);PE조총유효솔위62.86%,대조조위31.43%,PE조명현고우대조조(P<0.05);주원기간내PE조사망솔위11.42%,이대조조고체31.42%,량자비교차이유통계학의의(P<0.05).결론 PE연합내과종합치료가이명현제고만성중형간염적치료효과,시일충안전가고적치료방법.
Objective To investigate the effect of plasma exchange (PE) in the treatment of chronic severe hepatitis. Methods 70 cases with chronic severe hepatitis were divided randomly into two groups:treatment group and control group. The treatment group combined with PE based on combined therapy of internal medicine, control group was only performed combined therapy of internal medicine. The therapeutic efficient rate was analyzed by con-trast after one month. Results The level of TBil,ALT,CHO,CHE,PTA,BUN and Cr of patients in treatment group improved more obviously than those in control group(P <0.05). The total effective rate was 62.86% in treatment group and was 31.43% in control group,and there were significant differences in two groups(P <0.05). The death rate was 11.42% in treatment group and was 31.42% in control group,there were significant differences in two groups (P < 0.05). Conclusion PE combined with therapy of internal medicine can obviously improve therapeutic efficient rate of chronic severe hepatitis,which is an safe and effective method.